GB201009037D0 - Compositions and methods for treating disorders associated with atherosclerotic plaques - Google Patents

Compositions and methods for treating disorders associated with atherosclerotic plaques

Info

Publication number
GB201009037D0
GB201009037D0 GBGB1009037.1A GB201009037A GB201009037D0 GB 201009037 D0 GB201009037 D0 GB 201009037D0 GB 201009037 A GB201009037 A GB 201009037A GB 201009037 D0 GB201009037 D0 GB 201009037D0
Authority
GB
United Kingdom
Prior art keywords
compositions
methods
disorders associated
treating disorders
atherosclerotic plaques
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1009037.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Surrey
Original Assignee
University of Surrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Surrey filed Critical University of Surrey
Priority to GBGB1009037.1A priority Critical patent/GB201009037D0/en
Publication of GB201009037D0 publication Critical patent/GB201009037D0/en
Priority to PCT/GB2011/000815 priority patent/WO2011148147A1/en
Ceased legal-status Critical Current

Links

GBGB1009037.1A 2010-05-28 2010-05-28 Compositions and methods for treating disorders associated with atherosclerotic plaques Ceased GB201009037D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1009037.1A GB201009037D0 (en) 2010-05-28 2010-05-28 Compositions and methods for treating disorders associated with atherosclerotic plaques
PCT/GB2011/000815 WO2011148147A1 (en) 2010-05-28 2011-05-27 Compositions and methods for treating disorders associated with atherosclerotic plaques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1009037.1A GB201009037D0 (en) 2010-05-28 2010-05-28 Compositions and methods for treating disorders associated with atherosclerotic plaques

Publications (1)

Publication Number Publication Date
GB201009037D0 true GB201009037D0 (en) 2010-07-14

Family

ID=42371215

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1009037.1A Ceased GB201009037D0 (en) 2010-05-28 2010-05-28 Compositions and methods for treating disorders associated with atherosclerotic plaques

Country Status (2)

Country Link
GB (1) GB201009037D0 (en)
WO (1) WO2011148147A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019246282A1 (en) 2018-06-19 2019-12-26 The Regents Of The University Of Colorado Protection from stress, anxiety, neuroinflammation and cognitive dysfunction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2046830C (en) 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
DK0814778T3 (en) 1995-03-10 2001-09-17 Roche Diagnostics Gmbh Polypeptide-containing pharmaceutical administration forms in the form of microparticles and their method of preparation
US20030219453A1 (en) * 1998-03-19 2003-11-27 Smithkline Beecham Biologicals, Sa Vaccines
AU766959B2 (en) 1998-04-20 2003-10-30 Genzyme Corporation Drug delivery of proteins from polymeric blends

Also Published As

Publication number Publication date
WO2011148147A1 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
HK1246715A1 (en) Compositions and methods for targeted thermomodulation
HK1174064A1 (en) Methods and compositions for cell-proliferation-related disorders
IL226401A0 (en) Methods of treating fgf21-associated disorders
EP2406389A4 (en) Methods and compositions for cell-proliferation-related disorders
EP2552433A4 (en) Compositions and methods for the treatment of somatosensory disorders
HK1203830A1 (en) Compositions and methods for treating metabolic disorders
EP2655334A4 (en) Compositions and methods useful for treating diseases
EP2797620A4 (en) Methods and compositions for treating ineffective erythropoiesis
ZA201303423B (en) Compositions and methods for treating myelofibrosis
HRP20181950T1 (en) Samidorphan (alks 33) in combination with buprenorphine for the treatment of depressive disorders
ZA201304334B (en) Methods for diagnosing and treating eye-length related disorders
EP2523553A4 (en) Methods and compositions for treating bleeding disorders
EP2550361A4 (en) Compositions and methods for treating neurological disorders
EP2590674A4 (en) Compositions and methods for treating influenza
ZA201203002B (en) Compositions and methods for treating inflammatory disorders
HK1179823A1 (en) Methods for treating methotrexate-resistant disorders with 10-propargyl-10- deazaaminopterin 10--10-
WO2011112588A9 (en) Compositions and methods for treating inflammatory disorders
EP2558622A4 (en) Compositions and methods for identifying autism spectrum disorders
EP2688585A4 (en) Methods and compositions for improving antiangiogenic therapy with anti-integrins
EP2473171A4 (en) Methods of treating mitochondrial disorders using metalloporhyrins
AP2013007056A0 (en) Methods and compositions for treating kidney disorders
EP2643470A4 (en) Compositions and methods for diagnosing and treating diseases and disorders associated with d-dt
GB201009037D0 (en) Compositions and methods for treating disorders associated with atherosclerotic plaques

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)